GlassScriptPhysician profile
Steven Trey Fyfe
NPI 1154417707
$354.98
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $59.41.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $109.22 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $105.53 | 2019-2020 | |
| Optinose US, INC. | $56.99 | 2019 | |
| Axogen | $27.94 | 2019 | |
| Stryker Corporation | $20.57 | 2019 | |
| Genzyme Corporation | $20.33 | 2019 | |
| Becton, Dickinson and Company | $14.40 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Fyfe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.